Our Patient Commitment

As the end-user of our products and services, we are dedicated to improving the quality of life of our patients suffering from a variety of blood clotting disorders, immune deficiencies, and other illnesses.

Learn more 

The Octapharma mission "for the safe and optimal use of human proteins" conveys the company's focus and dedication to a specialized portfolio of products.



Explore our products 

News & Press Releases

Octapharma USA Sponsors ASA Symposium on Fibrinogen Supplementation in Surgical Patients

JAMA Publishes Clinical Study Results Comparing Fibrinogen Concentrate and Cryoprecipitate in Cardia...

FDA Approves Octapharma’s WILATE® for Hemophilia A in Adult and Adolescent Patients

HOBOKEN, N.J. (October 3, 2019) – Octapharma USA today announced the U.S. Food and Drug Administrati...